ArticleJournal for immunotherapy of cancer2024

Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors.

Nikhil I Khushalani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.